GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.95 $2.64 Friday, 19th Apr 2024 CHRS stock ended at $2.07. This is 3.50% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 7.18% from a day low at $1.95 to a day high of $2.09.
90 days $1.93 $2.97
52 weeks $1.44 $8.33

Historical Coherus BioSciences prices

Date Open High Low Close Volume
2020-08-14 $19.43 $19.57 $18.94 $19.07 473 939
2020-08-13 $18.80 $19.55 $18.80 $19.46 916 584
2020-08-12 $18.82 $19.11 $18.45 $18.90 888 254
2020-08-11 $18.76 $19.26 $18.51 $18.76 1 048 380
2020-08-10 $19.88 $20.06 $18.19 $18.75 1 161 100
2020-08-07 $19.95 $20.73 $18.47 $19.63 4 113 479
2020-08-06 $18.26 $18.27 $17.35 $17.41 848 636
2020-08-05 $18.13 $18.32 $17.78 $18.17 989 380
2020-08-04 $18.19 $18.35 $17.77 $17.90 694 581
2020-08-03 $17.62 $18.42 $17.45 $18.23 759 129
2020-07-31 $18.08 $18.30 $17.16 $17.59 1 053 104
2020-07-30 $17.99 $18.41 $17.82 $18.15 836 698
2020-07-29 $18.66 $18.75 $17.79 $18.19 1 105 732
2020-07-28 $18.85 $19.29 $18.33 $18.55 817 394
2020-07-27 $18.47 $18.97 $18.28 $18.92 620 536
2020-07-24 $17.87 $18.39 $17.55 $18.28 863 172
2020-07-23 $18.41 $18.48 $17.81 $18.02 741 944
2020-07-22 $18.76 $19.43 $18.18 $18.35 753 300
2020-07-21 $18.66 $18.98 $18.13 $18.66 818 400
2020-07-20 $18.63 $18.98 $18.46 $18.81 914 800
2020-07-17 $18.28 $18.55 $18.10 $18.47 700 800
2020-07-16 $18.21 $18.58 $17.87 $18.30 597 100
2020-07-15 $17.89 $18.55 $17.44 $18.52 1 342 500
2020-07-14 $17.80 $17.84 $17.03 $17.42 1 337 000
2020-07-13 $18.10 $18.46 $17.73 $17.75 823 800
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT